Skip to content

Apotheek Van Assche: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Apotheek Van Assche

BE 0832.466.074
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€17,529
2024 · €2,439+€15,090
Equity
€631,467
2024 · €613,938+€17,529
Cash
€120,688
2024 · €252,582-€131,893
Balance sheet total
€1.5m
2024 · €1.5m+€63,264

Largest movements

2024 to 2025
Assets
  • Cash -€131,893

    down €131,893 (-52.2%), from €252,582 to €120,688

    mainly Investment in fixed assets (net) (-€153,305) and Receivables within one year (-€72,066)

  • Tangible fixed assets +€100,899

    up €100,899 (+12.5%), from €807,840 to €908,738

    of which Plant, machinery and equipment: +€144,692

  • Receivables within one year +€72,066

    up €72,066 (+46.6%), from €154,787 to €226,853

    of which Trade receivables: +€39,351

Equity and liabilities
  • Debts after one year +€121,069

    up €121,069 (+19.1%), from €634,246 to €755,314

  • Other debts -€38,999

    down €38,999 (-54.1%), from €72,105 to €33,106

  • Tax, wage and social debts -€19,769

    down €19,769 (-54.2%), from €36,505 to €16,736

  • Reserves +€17,529

    up €17,529 (+2.9%), from €595,388 to €612,917

    of which Distributable reserves: +€17,529

  • Trade debts -€17,268

    down €17,268 (-20.3%), from €84,991 to €67,723

Income statement
  • Gross operating margin +€44,061

    up €44,061 (+14.3%), from €309,026 to €353,087

  • Financial charges +€17,756

    up €17,756 (+148%), from €11,970 to €29,726

  • Depreciation +€12,049

    up €12,049 (+29.9%), from €40,357 to €52,406

  • Staff costs +€6,551

    up €6,551 (+2.7%), from €239,220 to €245,771

  • Taxes -€6,145

    down €6,145 (-62.8%), from €9,782 to €3,637

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €2,439
Gross operating margin +€44,061
Staff costs -€6,551
Depreciation -€12,049
Other operating charges +€1,240
Financial charges -€17,756
Taxes +€6,145
Result 2025 €17,529
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€100,359
Investment -€153,305
Financing +€121,771
Cash 2024 €252,582
Net result for the year +€17,529
Depreciation +€52,406
Stocks and contracts -€14,807
Receivables within one year -€72,066
Deferred charges and accrued income -€7,386
Trade debts -€17,268
Tax, wage and social debts -€19,769
Other debts -€38,999
Investment in fixed assets (net) -€153,305
Debts after one year +€121,069
Current portion of long-term debt +€702
Cash 2025 €120,688
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,470,428 €1,533,693 +€63,264 +4.3%
Fixed assets 21/28 €807,840 €908,738 +€100,899 +12.5%
Tangible fixed assets 22/27 €807,840 €908,738 +€100,899 +12.5%
Land and buildings 22 €793,949 €750,156 -€43,793 -5.5%
Plant, machinery and equipment 23 €13,890 €158,582 +€144,692 +1,042%
Current assets 29/58 €662,589 €624,954 -€37,634 -5.7%
Stocks and contracts in progress 3 €234,672 €249,478 +€14,807 +6.3%
Stocks 30/36 €234,672 €249,478 +€14,807 +6.3%
Amounts receivable within one year 40/41 €154,787 €226,853 +€72,066 +46.6%
Trade receivables 40 €130,408 €169,758 +€39,351 +30.2%
Other amounts receivable 41 €24,379 €57,095 +€32,716 +134%
Cash at bank and in hand 54/58 €252,582 €120,688 -€131,893 -52.2%
Deferred charges and accrued income 490/1 €20,548 €27,934 +€7,386 +35.9%
Total equity and liabilities 10/49 €1,470,428 €1,533,693 +€63,264 +4.3%
Equity 10/15 €613,938 €631,467 +€17,529 +2.9%
Contributions 10/11 €18,550 €18,550 = 0.0%
Reserves 13 €595,388 €612,917 +€17,529 +2.9%
Tax-exempt reserves 132 €39 €39 = 0.0%
Distributable reserves 133 €595,349 €612,878 +€17,529 +2.9%
Profit (loss) carried forward 14 €0 - =
Amounts payable 17/49 €856,491 €902,226 +€45,735 +5.3%
Amounts payable after more than one year 17 €634,246 €755,314 +€121,069 +19.1%
Financial debts 170/4 €634,246 €755,314 +€121,069 +19.1%
Amounts payable within one year 42/48 €222,245 €146,911 -€75,334 -33.9%
Current portion of amounts payable after more than one year 42 €28,644 €29,346 +€702 +2.5%
Trade debts 44 €84,991 €67,723 -€17,268 -20.3%
Suppliers 440/4 €84,991 €67,723 -€17,268 -20.3%
Taxes, remuneration and social security 45 €36,505 €16,736 -€19,769 -54.2%
Remuneration and social security 454/9 €36,505 €16,736 -€19,769 -54.2%
Other amounts payable 47/48 €72,105 €33,106 -€38,999 -54.1%
Remuneration, social security and pensions 62 €239,220 €245,771 +€6,551 +2.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €40,357 €52,406 +€12,049 +29.9%
Other operating charges 640/8 €5,257 €4,017 -€1,240 -23.6%
Gross operating margin 9900 €309,026 €353,087 +€44,061 +14.3%
Operating profit (loss) 9901 €24,191 €50,892 +€26,701 +110%
Financial charges 65/66B €11,970 €29,726 +€17,756 +148%
Recurring financial charges 65 €11,970 €29,726 +€17,756 +148%
Profit (loss) for the period before taxes 9903 €12,221 €21,166 +€8,945 +73.2%
Income taxes 67/77 €9,782 €3,637 -€6,145 -62.8%
Profit (loss) for the period 9904 €2,439 €17,529 +€15,090 +619%
Profit (loss) for the period to be appropriated 9905 €2,439 €17,529 +€15,090 +619%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.